Neuroimaging in Alzheimer's disease: A synthesis and a contribution to the understanding of physiopathological mechanisms;Neuroimagerie de la maladie d'Alzheimer: synthèse et apport a la compréhension des mécanismes physiopathologiques

Biologie Aujourd'hui

Volumn 204, Issue 2, 2010, Pages 145-158

  Villain, Nicolas ^a   Chételat, Gael ^a   Desgranges, Béatrice ^a   Eustache, Francis ^a  

^a UNIVERSITÉ DE CAEN   (France)

Author keywords

Alzheimer's disease; atrophy; disconnection; hypometabolism; neuroimaging

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; ATROPHY; BRAIN; HISTOLOGY; HUMAN; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING;

ALZHEIMER DISEASE; ATROPHY; BRAIN; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY;

ANIMALIA;

EID: 78049459931     PISSN: 21050678     EISSN: 21050686     Source Type: Journal    
DOI: 10.1051/jbio/2010010     Document Type: Article

References (45)

1. Alzheimer's Disease International. World Alzheimer Report 2009.
2. Apostolova L.G., Thompson P.M., Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment. Neuropsychologia, 2008, 46, 1597-1612.
3. Bakkour A., Morris J.C., Dickerson B.C., The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Neurology, 2009, 72, 1048-1055.
4. Baron J.C., Bousser M.G., Comar D., Castaigne P., Crossed cerebellar diaschisis in human supratentorial infarction. Ann Neurol, 1980, 8, 128.
5. Baron J.C., Chételat G., Desgranges B., Perchey G., Landeau B., de la Sayette V., Eustache F., In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. NeuroImage, 2001, 14, 298-309.
6. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., Small G.W., Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med, 2000, 343, 450-456.
7. Buckner R.L., Andrews-Hanna J.R., Schacter D.L., The brain's default network: anatomy, function, and relevance to disease. Ann NY Acad Sci, 2008, 1124, 1-38.
8. Chételat G., Desgranges B., de la Sayette V., Viader F., Eustache F., Baron J.C., Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport, 2002, 13, 1939-1943.
9. Chételat G., Desgranges B., de la Sayette V., Viader F., Berkouk K., Landeau B., Lalevee C., Le Doze F., Dupuy B., Hannequin D., Baron J.C., Eustache F., Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment. Brain, 2003, 126, 1955-1967.
10. Chételat G., Desgranges B., de la Sayette V., Viader F., Eustache F., Baron J.C., Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology, 2003b, 60, 1374-1377.
11. Chételat G., Eustache F., Viader F., de la Sayette V., Pelerin A., Mezenge F., Hannequin D., Dupuy B., Baron J.C., Desgranges B., FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment. Neurocase, 2005, 11, 14-25.
12. Chételat G., Desgranges B., Landeau B., Mezenge F., Poline J.B., de la Sayette V., Viader F., Eustache F., Baron J.C., Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. Brain, 2008, 131, 60-71.
13. DeKosky S.T., Ikonomovic M.D., Styren S.D., Beckett L., Wisniewski S., Bennett D.A., Cochran E.J., Kordower J.H., Mufson E.J., Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol, 2002, 51, 145-155.
14. Desgranges B., Baron J.C., de la Sayette V., Petit-Taboué M.C., Benali K., Landeau B., Lechevalier B., Eustache F., The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Brain, 1998, 121, 611-631.
15. Desgranges B., Baron J.C., Lalevee C., Giffard B., Viader F., de la Sayette V., Eustache F., The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: relationship to degree of deterioration. Brain, 2002, 125, 1116-1124.
16. Drzezga A., Grimmer T., Henriksen G., Stangier I., Perneczky R., Diehl-Schmid J., Mathis C.A., Klunk W.E., Price J., DeKosky S., Wester H.J., Schwaiger M., Kurz A., Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease. NeuroImage, 2008, 39, 619-633.
17. Duyckaerts C., Potier M.C., Delatour B., Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathol, 2008, 115, 5-38.
18. Duyckaerts C., Delatour B., Potier M.C., Classification and basic pathology of Alzheimer disease. Acta Neuropathol, 2009, 118, 5-36.
19. Eustache F., Desgranges B., Giffard B., de la Sayette V., Baron J.C., Entorhinal cortex disruption causes memory deficit in early Alzheimer's disease as shown by PET. Neuroreport, 2001, 12, 683-685.
20. Eustache F., Piolino P., Giffard B., Viader F., de la Sayette V., Baron J.C., Desgranges B., In the course of time: a PET study of the cerebral substrates of autobiographical amnesia in Alzheimer's disease. Brain, 2004, 127, 1549-1560.
21. Fouquet M., Villain N., Chételat G., Eustache F., Desgranges B., Cerebral imaging and physiopathology of Alzheimer's disease. Psychol Neuropsychiatr Vieil, 2007, 5, 269-279.
22. Fouquet M., Desgranges B., Landeau B., Duchesnay E., Mezenge F., de la Sayette V., Viader F., Baron J.C., Eustache F., Chételat G., Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease. Brain, 2009, 132, 2058-2067.
23. Good C.D., Scahill R.I., Fox N.C., Ashburner J., Friston K.J., Chan D., Crum W.R., Rossor M.N., Frackowiak R.S., Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. NeuroImage, 2002, 17, 29-46.
24. Helmer C., Pasquier F., Dartigues J.F., Epidemiology of Alzheimer disease and related disorders. Med Sci (Paris), 2006, 22, 288-296.
25. Herholz K., Salmon E., Perani D., Baron J.C., Holthoff V., Frolich L., Schonknecht P., Ito K., Mielke R., Kalbe E., Zundorf G., Delbeuck X., Pelati O., Anchisi D., Fazio F., Kerrouche N., Desgranges B., Eustache F., Beuthien-Baumann B., Menzel C., Schroder J., Kato T., Arahata Y., Henze M., Heiss W.D., Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. NeuroImage, 2002, 17, 302-316.
26. Jagust W., Reed B., Mungas D., Ellis W., Decarli C., What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology, 2007, 69, 871-877.
27. Langbaum J.B., Chen K., Lee W., Reschke C., Bandy D., Fleisher A.S., Alexander G.E., Foster N.L., Weiner M.W., Koeppe R.A., Jagust W.J., Reiman E.M., Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). NeuroImage, 2009, 45, 1107-1116.
28. Mevel K., Desgranges B., Baron J.C., Landeau B., de la Sayette V., Viader F., Eustache F., Chételat G., Detecting hippocampal hypometabolism in Mild Cognitive Impairment using automatic voxel-based approaches. NeuroImage, 2007, 37, 18-25.
29. Mevel K., Grassiot B., Chételat G., Defer G., Desgranges B., Eustache F., The Default Mode Network: cognitive role and pathological disturbances. Rev Neurol (Paris). Sous Presse.
30. Misra C., Fan Y., Davatzikos C., Baseline, longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. NeuroImage, 2009, 44, 1415-1422.
31. Mosconi L., Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging, 2005, 32, 486-510.
32. Mosconi L., Pupi A., de Leon M.J., Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Ann NY Acad Sci, 2008, 1147, 180-195.
33. Mueller S.G., Weiner M.W., Selective effect of age, and Apo e4, and Alzheimer's disease on hippocampal subfields. Hippocampus, 2009, 19, 558-564.
34. Peters F., Collette F., Degueldre C., Sterpenich V., Majerus S., Salmon E., The neural correlates of verbal short-term memory in Alzheimer's disease: an fMRI study. Brain, 2009, 132, 1833-1846.
35. Prvulovic D., Van de Ven V., Sack A.T., Maurer K., Linden D.E., Functional activation imaging in aging and dementia. Psychiatry Res, 2005, 140, 97-113.
36. Risacher S.L., Saykin A.J., West J.D., Shen L., Firpi H.A., McDonald B.C., Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr Alzheimer Res, 2009, 6, 347-361.
37. Salmon E., Kerrouche N., Perani D., Lekeu F., Holthoff V., Beuthien-Baumann B., Sorbi S., Lemaire C., Collette F., Herholz K., On the multivariate nature of brain metabolic impairment in Alzheimer's disease. Neurobiol Aging, 2009, 30, 186-197.
38. Schroeter M.L., Stein T., Maslowski N., Neumann J., Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients. NeuroImage, 2009, 47, 1196-1206.
39. Schwindt G.C., Black S.E., Functional imaging studies of episodic memory in Alzheimer's disease: a quantitative meta-analysis. NeuroImage, 2009, 45, 181-190.
40. Seo S.W., Im K., Lee J.M., Kim Y.H., Kim S.T., Kim S.Y., Yang D.W., Kim S.I., Cho Y.S., Na D.L., Cortical thickness in single- versus multiple-domain amnestic mild cognitive impairment. NeuroImage, 2007, 36, 289-297.
41. Talairach J., Tournoux P., Co-planar stereotaxic atlas of the human brain. 1988, Thieme, New York.
42. Thompson P.M., Hayashi K.M., de Zubicaray G., Janke A.L., Rose S.E., Semple J., Herman D., Hong M.S., Dittmer S.S., Doddrell D.M., Toga A.W., Dynamics of gray matter loss in Alzheimer's disease. J Neurosci, 2003, 23, 994-1005.
43. Vemuri P., Wiste H.J., Weigand S.D., Shaw L.M., Trojanowski J.Q., Weiner M.W., Knopman D.S., Petersen R.C., Jack C.R. Jr., MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology, 2009, 73, 294-301.
44. Villain N., Desgranges B., Viader F., de la Sayette V., Mezenge F., Landeau B., Baron J.C., Eustache F., Chételat G., Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease. J Neurosci, 2008, 28, 6174-6181.
45. Villain N., Fouquet M., Baron J.C., Mezenge F., Landeau B., de la Sayette V., Viader F., Eustache F., Desgranges B., Chételat G., Sequential relationships between gray matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease. Soumis.